Management options for stage I seminoma.

Area of Science:

• Oncology
• Urology
• Clinical Management

Background:

• Stage I seminoma is the most frequent testicular cancer diagnosis.
• Orchiectomy is the primary treatment, with options like adjuvant radiotherapy, surveillance, and chemotherapy offering similar cure rates.
• Optimal management remains debated due to varying treatment pros, cons, and long-term outcomes.

Purpose of the Study:

• To review treatment alternatives for stage I seminoma post-orchiectomy.
• To discuss the pros, cons, and long-term outcomes of adjuvant radiotherapy, surveillance, and chemotherapy.
• To explore risk-adapted strategies considering patient-specific factors.

Main Methods:

• Literature review of existing studies and clinical data.
• Analysis of treatment efficacy, morbidity, and quality of life.
• Evaluation of predictive factors for relapse and patient preferences.

Main Results:

• Definitive cure is achievable with multiple treatment modalities.
• No consensus exists on the optimal management strategy.
• Risk-adapted approaches, including surveillance for low-risk patients and adjuvant therapy for high-risk or non-compliant patients, are emerging.

Conclusions:

• Treatment decisions should integrate burden of care, morbidity, cost, quality of life, and patient preferences.
• Risk-stratified management, balancing surveillance and adjuvant therapy, is a viable alternative to standard radiotherapy.
• Further validation of risk-adapted models is necessary for widespread adoption.